ciprofloxacin has been researched along with Campylobacter Infection in 160 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conducted a randomized controlled trial to determine whether empirical treatment of severe acute community-acquired gastroenteritis (four fluid stools per day for > 3 days) with ciprofloxacin reduces the duration of diarrhea and other symptoms and to determine what effect ciprofloxacin has on the duration of long-term fecal carriage of gastrointestinal pathogens." | 9.08 | Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. ( Dryden, MS; Gabb, RJ; Wright, SK, 1996) |
| "We evaluated the use of azithromycin (500 mg) or ciprofloxacin (500 mg) daily for 3 days for the treatment of acute diarrhea among United States military personnel in Thailand." | 9.08 | Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. ( Amato, S; Echeverria, P; Hoge, CW; Kuschner, RA; Olafson, RP; Pitarangsi, C; Sadoff, JC; Taylor, DN; Thomas, RJ; Trofa, AF, 1995) |
| "To determine the efficacy of loperamide given with long- and short-course quinolone therapy for treating traveler's diarrhea, 142 US military personnel were randomized to receive a single 750-mg dose of ciprofloxacin with placebo, 750 mg of ciprofloxacin with loperamide, or a 3-day course of 500 mg of ciprofloxacin twice daily with loperamide." | 9.07 | Treatment of traveler's diarrhea with ciprofloxacin and loperamide. ( DeFraites, R; Echeverria, P; Gelnett, J; Haberberger, RL; Murphy, GS; Petruccelli, BP; Sanchez, JL; Taylor, DN; Walz, S, 1992) |
| "In a double-blind, randomized trial, 85 adult patients with acute diarrhea (more than three watery stools per day) received either 500 mg of ciprofloxacin twice daily or placebo for five days." | 9.06 | Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea. ( Diridl, G; Pichler, HE; Stickler, K; Wolf, D, 1987) |
| "In a double-blind, randomized, placebo-controlled trial 50 adult patients with acute diarrhea received either 500 mg ciprofloxacin b." | 9.06 | Ciprofloxacin in the treatment of acute bacterial diarrhea: a double blind study. ( Diridl, G; Pichler, H; Wolf, D, 1986) |
| "Foreign travel remains the most important risk factor for ciprofloxacin-resistant Campylobacter infection." | 7.75 | Risk factors for ciprofloxacin-resistant Campylobacter infection in Wales. ( Evans, MR; Hopkins, AL; Northey, G; Rigby, CJ; Sarvotham, TS; Thomas, DR, 2009) |
| "We conducted a case-control study examining risk factors for ciprofloxacin resistance in Campylobacter infections that were reported in 2004 and 2005 in two health regions in southern Alberta." | 7.74 | Risk factors for ciprofloxacin resistance in reported Campylobacter infections in southern Alberta. ( Hasselback, P; Jhangri, G; Johnson, JY; Louie, M; McMullen, LM; Saunders, LD, 2008) |
| ", ciprofloxacin) are used to treat Campylobacter infections in adults." | 7.72 | Prolonged diarrhea due to ciprofloxacin-resistant campylobacter infection. ( Angulo, FJ; Hoekstra, RM; Joyce, K; Kassenborg, HD; Marano, N; Nelson, JM; Rabatsky-Ehr, T; Segler, SD; Smith, KE; Vugia, DJ; Zansky, SM, 2004) |
| "Although campylobacteriosis is usually a self-limited infection, antibiotics are indicated for severe and chronic conditions." | 5.48 | Genetic diversity and clonal characteristics of ciprofloxacin-resistant Campylobacter jejuni isolated from Chilean patients with gastroenteritis. ( Collado, L; Muñoz, I; Muñoz, N; Ochoa, S; Porte, L; Varela, C, 2018) |
| "We conducted a randomized controlled trial to determine whether empirical treatment of severe acute community-acquired gastroenteritis (four fluid stools per day for > 3 days) with ciprofloxacin reduces the duration of diarrhea and other symptoms and to determine what effect ciprofloxacin has on the duration of long-term fecal carriage of gastrointestinal pathogens." | 5.08 | Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. ( Dryden, MS; Gabb, RJ; Wright, SK, 1996) |
| "We evaluated the use of azithromycin (500 mg) or ciprofloxacin (500 mg) daily for 3 days for the treatment of acute diarrhea among United States military personnel in Thailand." | 5.08 | Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. ( Amato, S; Echeverria, P; Hoge, CW; Kuschner, RA; Olafson, RP; Pitarangsi, C; Sadoff, JC; Taylor, DN; Thomas, RJ; Trofa, AF, 1995) |
| "To determine the efficacy of loperamide given with long- and short-course quinolone therapy for treating traveler's diarrhea, 142 US military personnel were randomized to receive a single 750-mg dose of ciprofloxacin with placebo, 750 mg of ciprofloxacin with loperamide, or a 3-day course of 500 mg of ciprofloxacin twice daily with loperamide." | 5.07 | Treatment of traveler's diarrhea with ciprofloxacin and loperamide. ( DeFraites, R; Echeverria, P; Gelnett, J; Haberberger, RL; Murphy, GS; Petruccelli, BP; Sanchez, JL; Taylor, DN; Walz, S, 1992) |
| "From June 1985 to September 1987, 202 adults were enrolled in a randomized, double-blinded study comparing ciprofloxacin (500 mg) with sulfamethoxazole and trimethoprim (160 mg/800 mg) or placebo for adults with acute diarrhea." | 5.06 | Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. ( Goodman, LJ; Hines, D; Kaplan, RL; Landau, W; Mayer, KW; Nelson, JA; Parkhurst, GW; Petrak, R; Segreti, J; Trenholme, GM, 1990) |
| "In a double-blind, randomized, placebo-controlled trial 50 adult patients with acute diarrhea received either 500 mg ciprofloxacin b." | 5.06 | Ciprofloxacin in the treatment of acute bacterial diarrhea: a double blind study. ( Diridl, G; Pichler, H; Wolf, D, 1986) |
| "In a double-blind, randomized trial, 85 adult patients with acute diarrhea (more than three watery stools per day) received either 500 mg of ciprofloxacin twice daily or placebo for five days." | 5.06 | Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea. ( Diridl, G; Pichler, HE; Stickler, K; Wolf, D, 1987) |
| "This study was aimed at investigating the occurrence and genetic mechanisms of resistance to ciprofloxacin, tetracycline and erythromycin in clinical isolates of Campylobacter jejuni recovered from human cases of acute gastroenteritis in Turkey." | 3.91 | Antibiotic resistance of Campylobacter jejuni isolates recovered from humans with diarrhoea in Turkey. ( Abay, S; Aydin, F; Kayman, T; Şahin, O, 2019) |
| "Campylobacter was a major cause of diarrhea in children in two departments in Guatemala; antimicrobial resistance was high, and treatment regimens in the ambulatory setting which included metronidazole and trimethoprim-sulfamethoxazole and lacked oral rehydration were sub-optimal." | 3.80 | Burden of laboratory-confirmed Campylobacter infections in Guatemala 2008-2012: results from a facility-based surveillance system. ( Arvelo, W; Benoit, SR; Henao, O; Lindblade, K; Lopez, B; Moir, JC; Parsons, MB; Reyes, L, 2014) |
| " We conducted a prospective study to know the incidence of Campylobacter jejuni bacteremia in pediatric patients and its susceptibility to erythromycin and ciprofloxacin." | 3.79 | [Incidence and susceptibility of Campylobacter jejuni in pediatric patients: involvement in bacteremia]. ( Alonso-Sanz, M; González-Abad, MJ, 2013) |
| "Over half (55%) of the campylobacter infections acquired abroad were resistant to ciprofloxacin, compared with 10% of UK-acquired strains [relative risk 5." | 3.71 | Ciprofloxacin resistance in Campylobacter jejuni: case-case analysis as a tool for elucidating risks at home and abroad. ( , 2002) |
| "Rifaximin did not prevent campylobacteriosis in this controlled human infection model." | 2.87 | Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled Trial. ( Alcala, A; Brubaker, J; Chakraborty, S; DeNearing, B; Gariepy, CL; Guerry, P; Gutierrez, RL; Harro, C; Jaep, K; Laird, RM; Maue, AC; Mochalova, Y; Poly, F; Porter, CK; Riddle, MS; Rimmer, JE; Sack, DA; Talaat, KR; Tribble, DR, 2018) |
| "The incidence of human Campylobacter infection has increased markedly in both developed and developing countries and, more significantly, so has rapid emergence of antibiotic-resistant Campylobacter strains." | 2.46 | [Antibiotic resistance of bacteria Campylobacter sp]. ( Korsak, D; Maćkiw, E; Rzewuska, K, 2010) |
| "Campylobacteriosis is one of the most common zoonotic diseases in North America." | 1.91 | Antimicrobial use and its association with the isolation of and antimicrobial resistance in Campylobacter spp. recovered from fecal samples from Canadian dairy herds: A cross-sectional study. ( Barkema, HW; Dufour, S; Fonseca, M; Heider, LC; Kelton, DF; Léger, D; McClure, JT; Renaud, D; Rizzo, D; Roy, JP; Sanchez, J; Stryhn, H; Warder, L, 2023) |
| "Poultry is the primary source of Campylobacter infections and severe campylobacteriosis cases are treated with macrolides and fluoroquinolones." | 1.91 | Prevalence of ciprofloxacin resistance and associated genetic determinants differed among Campylobacter isolated from human and poultry meat sources in Pennsylvania. ( Denes, TG; Hudson, LK; Kovac, J; M'ikanatha, NM; Nachamkin, I; Yan, R, 2023) |
| "Chicken is a major source of human campylobacteriosis." | 1.72 | Campylobacter spp. prevalence and fluoroquinolone resistance in chicken layer farms. ( Asakura, H; Igimi, S; Iwata, T; Sasaki, Y; Uema, M; Yonemitsu, K, 2022) |
| "Campylobacter infections are typically self-limited, but in cases with severe enteritis, immuno-compromised system and bacteremia, an appropriate antimicrobial treatment is demanding." | 1.51 | Antimicrobial Susceptibility of Campylobacter isolates in the Capital of North Macedonia. ( Blazevska, A; Kostovski, M; Mihajlov, K; Mirchevska, G; Stojkovska, S; Trajkovska-Dokic, E, 2019) |
| "Incidence of ciprofloxacin-resistant Campylobacter infections among humans has increased over the last several years." | 1.51 | Ciprofloxacin resistance among Campylobacter jejuni isolates obtained from shelter dogs in Texas. ( Cummings, KJ; LaLonde-Paul, D; Lawhon, SD; Rodriguez-Rivera, LD; Wu, J, 2019) |
| "Most Campylobacter infections are self-limiting, but antimicrobial treatment (e." | 1.48 | High Prevalence of Resistance to Fluoroquinolones and Tetracycline Campylobacter Spp. Isolated from Poultry in Poland. ( Bugla-Płoskońska, G; Kielsznia, A; Korzekwa, K; Korzeniowska-Kowal, A; Tobiasz, A; Wieliczko, A; Woźniak-Biel, A, 2018) |
| "Although campylobacteriosis is usually a self-limited infection, antibiotics are indicated for severe and chronic conditions." | 1.48 | Genetic diversity and clonal characteristics of ciprofloxacin-resistant Campylobacter jejuni isolated from Chilean patients with gastroenteritis. ( Collado, L; Muñoz, I; Muñoz, N; Ochoa, S; Porte, L; Varela, C, 2018) |
| "Campylobacteriosis is a dominant bacterial cause of foodborne infection and is considered the main public health problem in Europe and many other countries worldwide." | 1.46 | Prevalence and antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolated from children and environmental sources in urban and suburban areas. ( Andrzejewska, M; Klawe, JJ; Spica, D; Szczepanska, B, 2017) |
| "Remarkably, clonal spread of food poisoning pathogens between animals and humans was confirmed by population genetic analysis." | 1.46 | Epidemiological relationships of Campylobacter jejuni strains isolated from humans and chickens in South Korea. ( Jang, HK; Jung, SC; Kang, MS; Kim, CH; Kwon, YK; Lim, SK; Oh, JY; Wei, B, 2017) |
| "Campylobacter infection is a common cause of diarrhea among international travelers." | 1.46 | Antibiotic susceptibility profiles among Campylobacter isolates obtained from international travelers between 2007 and 2014. ( Bottieau, E; Hallin, M; Jacobs, J; Maniewski, U; Martiny, D; Ombelet, S; Post, A; Van Esbroeck, M; van Waterschoot, N; Vandenberg, O; Vlieghe, E, 2017) |
| "Despite the fact that most Campylobacter infections in humans cure on their own, the resistance of the causative strains to the antimicrobials of choice and alternative agents needs to be studied because of its relevance to the treatment of severe cases that require antibiotics." | 1.40 | [Resistance monitoring working group: resistance to erythromycin, ciprofloxacin, and tetracycline in human isolates of Campylobacter spp. in the Czech Republic tested by the EUCAST standard method]. ( Jakubů, V; Marejková, M; Urbášková, P; Žemličková, H, 2014) |
| "The ciprofloxacin MIC was above the ECOFF for 22% of the isolates, and one Camp." | 1.39 | Absence of tetracycline resistance in Campylobacter coli isolates from Finnish finishing pigs treated with chlortetracycline. ( Hänninen, ML; Heinonen, M; Juntunen, P; Laurila, T, 2013) |
| "All ciprofloxacin MICs were below the ECOFF (≤ 1 μg/mL), except for three isolates from untreated sows and four isolates after aminopenicillin therapy." | 1.38 | Campylobacter coli isolates from Finnish farrowing farms using aminopenicillins: high prevalence of bla(OXA-61) and β-lactamase production, but low MIC values. ( Hänninen, ML; Heiska, H; Juntunen, P, 2012) |
| "Sweet's syndrome or acute febrile neutrophilic dermatosis has been associated with underlying infection, malignancy, inflammatory disease and certain medications." | 1.38 | Campylobacter gastroenteritis associated with Sweet's syndrome. ( Aliyu, SH; Karas, JA; Pai, S; Rytina, E; Sterling, J, 2012) |
| "Danofloxacin-treated (n=12, group A) and control pigs (n=15, group B) were subsequently treated with tylosin and sampled longitudinally." | 1.37 | Longitudinal on-farm study of the development of antimicrobial resistance in Campylobacter coli from pigs before and after danofloxacin and tylosin treatments. ( Hänninen, ML; Juntunen, P; Olkkola, S, 2011) |
| "We report here the first case of C." | 1.36 | Spondylodiscitis and an aortic aneurysm due to Campylobacter coli. ( Bournet, BS; Cattoen, C; Dehecq, C; Garnier, LD; Lemaire, X; Senneville, E; Yazdanpanah, Y, 2010) |
| "Its efficacy for the treatment of human campylobacteriosis should be evaluated in clinical trials." | 1.36 | Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents. ( Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A, 2010) |
| "Cases with confirmed Campylobacter infection were sampled through the national surveillance laboratory network." | 1.35 | Risk factors for acquiring sporadic Campylobacter infection in France: results from a national case-control study. ( Bousquet, V; Desenclos, JC; Gallay, A; Le Strat, Y; Mégraud, F; Prouzet-Mauléon, V; Simon, F; Siret, V; Vaillant, V; Valk, Hd, 2008) |
| "The proven shigellosis as well as the strong suspicion have to be treated promptly with antibiotics, mainly azithromycin." | 1.35 | [Bacterial diarrheas and antibiotics: European recommendations]. ( Cohen, R; Gendrel, D, 2008) |
| "Ciprofloxacin resistance was not associated with particularly severe infection." | 1.35 | Severe diarrhoea caused by highly ciprofloxacin-susceptible Campylobacter isolates. ( Feodoroff, FB; Hänninen, ML; Lauhio, AR; Rautelin, HI; Sarna, SJ, 2009) |
| "To detect campylobacteriosis and determine the drug susceptibility of causative organisms, we acquired 500 diarrheic samples in Cary-Blair transfer medium from two pediatric hospitals in Tehran between October 2004 and October 2005." | 1.34 | Isolation and drug-resistant patterns of Campylobacter strains cultured from diarrheic children in Tehran. ( Dolatabadi, S; Feizabadi, MM; Zali, MR, 2007) |
| "Enrofloxacin treatment of chickens infected with fluoroquinolone(FQ)-sensitive Campylobacter promoted the emergence of FQ-resistant Campylobacter mutants which propagated in the intestinal tract and recolonized the chickens." | 1.32 | In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump. ( Lin, J; Luo, N; Michel, LO; Sahin, O; Zhang, Q, 2003) |
| "Ciprofloxacin resistance was analyzed in 354 Campylobacter jejuni isolates collected during two study periods (1995-1997 and 1998-2000) from travelers returning to Finland." | 1.32 | Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland: association of ciprofloxacin resistance to travel destination. ( Hakanen, A; Huovinen, P; Jousimies-Somer, H; Kotilainen, P; Siitonen, A, 2003) |
| "Ciprofloxacin resistance has emerged among Campylobacter since 1990 and has increased in prevalence since 1997." | 1.32 | Antimicrobial resistance among Campylobacter strains, United States, 1997-2001. ( Angulo, FJ; Barrett, TJ; Beebe, JL; Benson, JA; Friedman, CR; Gupta, A; Hawkins, MA; Jones, TF; Joyce, KW; Nelson, JM; Rabatsky-Ehr, T; Root, TP; Rossiter, SP; Shiferaw, B; Smith, KE; Tauxe, RV; Vugia, DJ, 2004) |
| "We describe a case of infectious arthritis caused by C." | 1.29 | Campylobacter jejuni arthritis in secondary amyloidosis. ( Markusse, HM; Simon, CH, 1995) |
| "Ciprofloxacin accumulation was diminished in the two resistant posttreatment isolates." | 1.28 | High-level quinolone resistance in clinical isolates of Campylobacter jejuni. ( Goodman, LJ; Gootz, TD; Martin, BA; Parkhurst, GW; Quinn, JP; Segreti, J; Trenholme, GM, 1992) |
| "Ciprofloxacin was compared with erythromycin for the eradication of Campylobacter species that were chronically excreted in the stools of marmosets (Saguinus labiatus labiatus, Saguinus fuscicollis nigrifrons, and Saguinus fuscicollis illigeri)." | 1.27 | Effects of erythromycin and ciprofloxacin on chronic fecal excretion of Campylobacter species in marmosets. ( Fliegelman, RM; Goodman, LJ; Kaplan, RL; Penner, JL; Petrak, RM; Taff, D; Trenholme, GM; Walton, F, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (3.13) | 18.7374 |
| 1990's | 33 (20.63) | 18.2507 |
| 2000's | 49 (30.63) | 29.6817 |
| 2010's | 56 (35.00) | 24.3611 |
| 2020's | 17 (10.63) | 2.80 |
| Authors | Studies |
|---|---|
| Lehtopolku, M | 2 |
| Nakari, UM | 1 |
| Kotilainen, P | 4 |
| Huovinen, P | 4 |
| Siitonen, A | 4 |
| Hakanen, AJ | 2 |
| Sasaki, Y | 3 |
| Iwata, T | 1 |
| Uema, M | 3 |
| Yonemitsu, K | 3 |
| Igimi, S | 1 |
| Asakura, H | 2 |
| Lopez-Cantillo, M | 1 |
| Opazo-Capurro, A | 1 |
| Lopez-Joven, C | 1 |
| Vidal-Veuthey, B | 1 |
| Collado, L | 2 |
| Asai, T | 2 |
| Debelo, M | 1 |
| Mohammed, N | 1 |
| Tiruneh, A | 1 |
| Tolosa, T | 1 |
| Emami, MS | 1 |
| Shakerian, A | 1 |
| Chaleshtori, RS | 1 |
| Rahimi, E | 1 |
| Ikeda, T | 1 |
| Kuroda, M | 1 |
| Ogawa, M | 1 |
| Sakata, R | 1 |
| Momose, Y | 1 |
| Ohya, K | 1 |
| Watanabe, M | 1 |
| Hara-Kudo, Y | 1 |
| Okamura, M | 1 |
| Dias, TS | 1 |
| de Almeida Figueira, A | 1 |
| Costa, GA | 1 |
| da Cunha, NC | 1 |
| Rossi, DA | 1 |
| de Melo, RT | 1 |
| de Almeida Pereira, VL | 1 |
| de Aquino, MHC | 1 |
| Fonseca, M | 1 |
| Heider, LC | 1 |
| Stryhn, H | 1 |
| McClure, JT | 1 |
| Léger, D | 1 |
| Rizzo, D | 1 |
| Warder, L | 1 |
| Dufour, S | 1 |
| Roy, JP | 1 |
| Kelton, DF | 1 |
| Renaud, D | 1 |
| Barkema, HW | 1 |
| Sanchez, J | 1 |
| Yan, R | 1 |
| M'ikanatha, NM | 1 |
| Nachamkin, I | 1 |
| Hudson, LK | 1 |
| Denes, TG | 1 |
| Kovac, J | 2 |
| Hizlisoy, H | 1 |
| Sagiroglu, P | 1 |
| Barel, M | 1 |
| Dishan, A | 1 |
| Gungor, C | 1 |
| Koskeroglu, K | 1 |
| Hizlisoy, S | 1 |
| Atalay, MA | 1 |
| Trajkovska-Dokic, E | 1 |
| Mihajlov, K | 1 |
| Mirchevska, G | 1 |
| Kostovski, M | 1 |
| Blazevska, A | 1 |
| Stojkovska, S | 1 |
| Ilktac, M | 1 |
| Ongen, B | 1 |
| Humphrey, TJ | 2 |
| Williams, LK | 1 |
| Šimunović, K | 1 |
| Sahin, O | 5 |
| Shen, Z | 2 |
| Klančnik, A | 1 |
| Zhang, Q | 4 |
| Smole Možina, S | 2 |
| Kouglenou, SD | 1 |
| Agbankpe, AJ | 1 |
| Dougnon, V | 1 |
| Djeuda, AD | 1 |
| Deguenon, E | 1 |
| Hidjo, M | 1 |
| Baba-Moussa, L | 1 |
| Bankole, H | 1 |
| Espinoza, N | 1 |
| Rojas, J | 1 |
| Pollett, S | 2 |
| Meza, R | 2 |
| Patiño, L | 2 |
| Leiva, M | 1 |
| Camiña, M | 2 |
| Bernal, M | 2 |
| Reynolds, ND | 1 |
| Maves, R | 2 |
| Tilley, DH | 1 |
| Kasper, M | 2 |
| Simons, MP | 1 |
| Nafarrate, I | 1 |
| Lasagabaster, A | 1 |
| Sevillano, E | 1 |
| Mateo, E | 1 |
| Forson, AO | 1 |
| Adjei, DN | 1 |
| Olu-Taiwo, M | 1 |
| Quarchie, MN | 1 |
| Asmah, HR | 1 |
| Hansson, I | 1 |
| Tamminen, LM | 1 |
| Frosth, S | 1 |
| Fernström, LL | 1 |
| Emanuelson, U | 1 |
| Boqvist, S | 1 |
| Szczepanska, B | 1 |
| Andrzejewska, M | 1 |
| Spica, D | 1 |
| Klawe, JJ | 1 |
| Post, A | 1 |
| Martiny, D | 1 |
| van Waterschoot, N | 1 |
| Hallin, M | 1 |
| Maniewski, U | 1 |
| Bottieau, E | 1 |
| Van Esbroeck, M | 1 |
| Vlieghe, E | 1 |
| Ombelet, S | 1 |
| Vandenberg, O | 1 |
| Jacobs, J | 1 |
| Woźniak-Biel, A | 1 |
| Bugla-Płoskońska, G | 1 |
| Kielsznia, A | 1 |
| Korzekwa, K | 1 |
| Tobiasz, A | 1 |
| Korzeniowska-Kowal, A | 1 |
| Wieliczko, A | 1 |
| Edson, RS | 1 |
| Litin, SC | 1 |
| Bundrick, JB | 1 |
| Kiyasu, Y | 1 |
| Akiyama, D | 1 |
| Kurihara, Y | 1 |
| Koganemaru, H | 1 |
| Hitomi, S | 1 |
| Puljiz, I | 1 |
| Topic, A | 1 |
| Rimmer, JE | 2 |
| Harro, C | 2 |
| Sack, DA | 1 |
| Talaat, KR | 2 |
| Gutierrez, RL | 2 |
| DeNearing, B | 2 |
| Brubaker, J | 2 |
| Laird, RM | 2 |
| Poly, F | 1 |
| Maue, AC | 2 |
| Jaep, K | 2 |
| Alcala, A | 2 |
| Mochalova, Y | 1 |
| Gariepy, CL | 1 |
| Chakraborty, S | 1 |
| Guerry, P | 2 |
| Tribble, DR | 2 |
| Porter, CK | 2 |
| Riddle, MS | 3 |
| Muñoz, N | 1 |
| Porte, L | 1 |
| Ochoa, S | 1 |
| Varela, C | 1 |
| Muñoz, I | 1 |
| Crofts, AA | 1 |
| Poly, FM | 1 |
| Ewing, CP | 1 |
| Kuroiwa, JM | 1 |
| Sack, D | 1 |
| Ramakrishnan, A | 1 |
| McCoy, AJ | 1 |
| Davies, BW | 1 |
| Trent, MS | 1 |
| Azrad, M | 1 |
| Tkhawkho, L | 1 |
| Isakovich, N | 1 |
| Nitzan, O | 1 |
| Peretz, A | 1 |
| Bénéjat, L | 1 |
| Sifré, E | 1 |
| Domingues Martins, C | 1 |
| Ducournau, A | 1 |
| Buissonnière, A | 1 |
| Bessède, E | 1 |
| Mégraud, F | 2 |
| Lehours, P | 1 |
| Laenens, D | 1 |
| Plazier, M | 1 |
| van der Hilst, JCH | 1 |
| Messiaen, P | 1 |
| Dawadi, S | 1 |
| Elhadidy, M | 1 |
| Miller, WG | 1 |
| Arguello, H | 1 |
| Álvarez-Ordóñez, A | 1 |
| Dierick, K | 1 |
| Botteldoorn, N | 1 |
| LaLonde-Paul, D | 1 |
| Cummings, KJ | 1 |
| Rodriguez-Rivera, LD | 1 |
| Wu, J | 1 |
| Lawhon, SD | 1 |
| Kayman, T | 1 |
| Abay, S | 1 |
| Aydin, F | 1 |
| Yamada, K | 1 |
| Saito, R | 1 |
| Muto, S | 1 |
| Sasaki, M | 1 |
| Murakami, H | 1 |
| Aoki, K | 1 |
| Ishii, Y | 1 |
| Tateda, K | 1 |
| Abbasi, E | 1 |
| van Belkum, A | 1 |
| Ghaznavi-Rad, E | 1 |
| García-Sánchez, L | 1 |
| Melero, B | 1 |
| Jaime, I | 1 |
| Rossi, M | 1 |
| Ortega, I | 1 |
| Rovira, J | 1 |
| Meistere, I | 1 |
| Ķibilds, J | 1 |
| Eglīte, L | 1 |
| Alksne, L | 1 |
| Avsejenko, J | 1 |
| Cibrovska, A | 1 |
| Makarova, S | 1 |
| Streikiša, M | 1 |
| Grantiņa-Ieviņa, L | 1 |
| Bērziņš, A | 1 |
| Ellström, P | 1 |
| Feodoroff, B | 1 |
| Hänninen, ML | 5 |
| Rautelin, H | 1 |
| Gaudreau, C | 5 |
| Helferty, M | 1 |
| Sylvestre, JL | 1 |
| Allard, R | 1 |
| Pilon, PA | 2 |
| Poisson, M | 1 |
| Bekal, S | 3 |
| González-Abad, MJ | 1 |
| Alonso-Sanz, M | 1 |
| Sanz-Rodríguez, N | 1 |
| Pérez-Pomata, MT | 1 |
| Stelmakh, O | 1 |
| Pérez-Boto, D | 1 |
| Gómez-Garcés, JL | 1 |
| Teske, L | 1 |
| Ryll, M | 1 |
| Rubbenstroth, D | 1 |
| Hänel, I | 1 |
| Hartmann, M | 1 |
| Kreienbrock, L | 1 |
| Rautenschlein, S | 1 |
| Benoit, SR | 1 |
| Lopez, B | 1 |
| Arvelo, W | 1 |
| Henao, O | 1 |
| Parsons, MB | 1 |
| Reyes, L | 1 |
| Moir, JC | 1 |
| Lindblade, K | 1 |
| Boucher, F | 1 |
| Gilbert, H | 2 |
| Mahmood, A | 1 |
| Al Hakawati, MI | 1 |
| Žemličková, H | 1 |
| Jakubů, V | 1 |
| Marejková, M | 1 |
| Urbášková, P | 1 |
| Dai, L | 1 |
| Muraoka, WT | 1 |
| Wu, Z | 1 |
| Rodrigues-Coutlée, S | 1 |
| Coutlée, F | 1 |
| Lübbert, C | 1 |
| Lapierre, L | 1 |
| Gatica, MA | 1 |
| Riquelme, V | 1 |
| Vergara, C | 1 |
| Yañez, JM | 1 |
| San Martín, B | 1 |
| Sáenz, L | 1 |
| Vidal, M | 1 |
| Martínez, MC | 1 |
| Araya, P | 1 |
| Flores, R | 1 |
| Duery, O | 1 |
| Vidal, R | 1 |
| Sierra-Arguello, YM | 1 |
| Perdoncini, G | 1 |
| Morgan, RB | 1 |
| Salle, CT | 1 |
| Moraes, HL | 1 |
| Gomes, MJ | 1 |
| do Nascimento, VP | 1 |
| Kim, JS | 1 |
| Lee, MY | 1 |
| Kim, SJ | 1 |
| Jeon, SE | 1 |
| Cha, I | 1 |
| Hong, S | 1 |
| Chung, GT | 1 |
| Huh, MJ | 1 |
| Kang, YH | 1 |
| Yoo, CK | 1 |
| Kim, J | 1 |
| Jurado-Tarifa, E | 1 |
| Torralbo, A | 1 |
| Borge, C | 1 |
| Cerdà-Cuéllar, M | 1 |
| Ayats, T | 1 |
| Carbonero, A | 1 |
| García-Bocanegra, I | 1 |
| Oh, JY | 1 |
| Kwon, YK | 1 |
| Wei, B | 1 |
| Jang, HK | 1 |
| Lim, SK | 1 |
| Kim, CH | 1 |
| Jung, SC | 1 |
| Kang, MS | 1 |
| Taylor, NM | 1 |
| Davies, RH | 1 |
| Ridley, A | 1 |
| Clouting, C | 1 |
| Wales, AD | 1 |
| Clifton-Hadley, FA | 1 |
| Gendrel, D | 1 |
| Cohen, R | 1 |
| Feodoroff, FB | 1 |
| Lauhio, AR | 1 |
| Sarna, SJ | 1 |
| Rautelin, HI | 1 |
| Evans, MR | 1 |
| Northey, G | 1 |
| Sarvotham, TS | 1 |
| Hopkins, AL | 1 |
| Rigby, CJ | 1 |
| Thomas, DR | 1 |
| Soonthornchaikul, N | 1 |
| Garelick, H | 1 |
| Lemaire, X | 1 |
| Dehecq, C | 1 |
| Cattoen, C | 1 |
| Garnier, LD | 1 |
| Bournet, BS | 1 |
| Yazdanpanah, Y | 1 |
| Senneville, E | 1 |
| Thakur, S | 2 |
| Zhao, S | 1 |
| McDermott, PF | 2 |
| Harbottle, H | 1 |
| Abbott, J | 1 |
| English, L | 1 |
| Gebreyes, WA | 2 |
| White, DG | 1 |
| Rzewuska, K | 1 |
| Korsak, D | 1 |
| Maćkiw, E | 1 |
| Cody, AJ | 1 |
| Clarke, L | 2 |
| Bowler, IC | 2 |
| Dingle, KE | 2 |
| Juntunen, P | 3 |
| Olkkola, S | 1 |
| Sonnevend, Á | 2 |
| Kovács, J | 1 |
| Pál, T | 2 |
| Akawi, N | 1 |
| Nagelkerke, N | 1 |
| Schneider, G | 1 |
| Noormohamed, A | 1 |
| Fakhr, MK | 1 |
| Bousquet, A | 1 |
| Demoures, T | 1 |
| Malfuson, JV | 1 |
| Martinaud, C | 1 |
| Soler, C | 1 |
| Pai, S | 1 |
| Rytina, E | 1 |
| Sterling, J | 1 |
| Karas, JA | 1 |
| Aliyu, SH | 1 |
| Zaidi, MB | 1 |
| Campos, FD | 1 |
| Chim, R | 1 |
| Leon, M | 1 |
| Vazquez, G | 1 |
| Figueroa, G | 1 |
| Lopez, E | 1 |
| Contreras, J | 1 |
| Estrada-Garcia, T | 1 |
| Rocha, C | 1 |
| Zerpa, R | 1 |
| Valencia, A | 1 |
| Guevara, J | 1 |
| Lopez, M | 1 |
| Chuquiray, N | 1 |
| Salazar-Lindo, E | 1 |
| Calampa, C | 1 |
| Casapia, M | 1 |
| Tilley, D | 1 |
| Gregory, M | 1 |
| Hall, E | 1 |
| Jones, F | 1 |
| Arriola, CS | 1 |
| Rosenbaum, M | 1 |
| Perez, J | 1 |
| Heiska, H | 1 |
| Sanad, YM | 1 |
| Closs, G | 1 |
| Kumar, A | 1 |
| LeJeune, JT | 1 |
| Rajashekara, G | 1 |
| Laurila, T | 1 |
| Heinonen, M | 1 |
| Mavri, A | 1 |
| El-Adawy, H | 1 |
| Hotzel, H | 1 |
| Düpre, S | 1 |
| Tomaso, H | 1 |
| Neubauer, H | 1 |
| Hafez, HM | 1 |
| Hakanen, A | 2 |
| Jalava, J | 1 |
| Jousimies-Somer, H | 2 |
| Cooper, R | 1 |
| Segal, H | 1 |
| Lastovica, AJ | 1 |
| Elisha, BG | 1 |
| Luo, N | 1 |
| Lin, J | 1 |
| Michel, LO | 1 |
| Menzies, F | 1 |
| McDowell, S | 1 |
| Neill, S | 1 |
| Hein, I | 1 |
| Schneck, C | 1 |
| Knögler, M | 1 |
| Feierl, G | 1 |
| Plesss, P | 1 |
| Köfer, J | 1 |
| Achmann, R | 1 |
| Wagner, M | 1 |
| Michaud, S | 1 |
| Osterlund, A | 1 |
| Hermann, M | 1 |
| Kahlmeter, G | 1 |
| Putnam, SD | 1 |
| Frenck, RW | 1 |
| El-Gendy, A | 1 |
| Taha, NN | 1 |
| Pittner, BT | 1 |
| Abu-Elyazeed, R | 1 |
| Wierzba, TF | 1 |
| Rao, MR | 1 |
| Savarino, SJ | 1 |
| Clemens, JD | 1 |
| Radostits, OM | 1 |
| Gupta, A | 1 |
| Nelson, JM | 2 |
| Barrett, TJ | 1 |
| Tauxe, RV | 1 |
| Rossiter, SP | 1 |
| Friedman, CR | 1 |
| Joyce, KW | 1 |
| Smith, KE | 3 |
| Jones, TF | 1 |
| Hawkins, MA | 1 |
| Shiferaw, B | 1 |
| Beebe, JL | 1 |
| Vugia, DJ | 2 |
| Rabatsky-Ehr, T | 2 |
| Benson, JA | 1 |
| Root, TP | 1 |
| Angulo, FJ | 2 |
| Segler, SD | 1 |
| Kassenborg, HD | 1 |
| Zansky, SM | 1 |
| Joyce, K | 1 |
| Marano, N | 1 |
| Hoekstra, RM | 1 |
| Monno, R | 1 |
| Rendina, M | 1 |
| Ceci, G | 1 |
| Rizzo, C | 1 |
| Luzzi, I | 1 |
| Francavilla, A | 1 |
| Rizzo, G | 1 |
| Ierardi, E | 1 |
| Jørgensen, F | 2 |
| Frost, JA | 2 |
| Wadda, H | 1 |
| Domingue, G | 1 |
| Elviss, NC | 1 |
| Griggs, DJ | 2 |
| Piddock, LJ | 2 |
| Johnson, MM | 1 |
| Humphrey, T | 1 |
| Cox, LA | 1 |
| Copeland, D | 1 |
| Vaughn, M | 1 |
| Ismaeel, AY | 1 |
| Senok, AC | 1 |
| Bindayna, KM | 1 |
| Bakhiet, M | 1 |
| Al Mahmeed, A | 1 |
| Yousif, AQ | 1 |
| Botta, GA | 1 |
| Reda, E | 1 |
| Mansell, C | 1 |
| Corcoran, D | 2 |
| Quinn, T | 1 |
| Cotter, L | 1 |
| Fanning, S | 2 |
| Rodríguez-Avial, I | 1 |
| Rodríguez-Avial, C | 1 |
| López, O | 1 |
| Culebras, E | 1 |
| Picazo, JJ | 1 |
| Unicomb, LE | 1 |
| Ferguson, J | 1 |
| Stafford, RJ | 1 |
| Ashbolt, R | 1 |
| Kirk, MD | 1 |
| Becker, NG | 1 |
| Patel, MS | 1 |
| Gilbert, GL | 2 |
| Valcanis, M | 1 |
| Mickan, L | 1 |
| Minihan, D | 1 |
| Whyte, P | 1 |
| O'mahony, M | 1 |
| Cowley, D | 1 |
| O'halloran, F | 1 |
| Collins, JD | 1 |
| Idris, U | 1 |
| Lu, J | 1 |
| Maier, M | 1 |
| Sanchez, S | 1 |
| Hofacre, CL | 1 |
| Harmon, BG | 1 |
| Maurer, JJ | 1 |
| Lee, MD | 1 |
| Rotimi, VO | 1 |
| Kolodziejek, J | 1 |
| Usmani, A | 1 |
| Nowotny, N | 1 |
| Senok, A | 1 |
| Yousif, A | 1 |
| Mazi, W | 1 |
| Sharaf, E | 1 |
| Bindayna, K | 1 |
| Elnima, el-A | 1 |
| Botta, G | 1 |
| Wassenaar, TM | 1 |
| Kist, M | 1 |
| de Jong, A | 1 |
| Englen, MD | 1 |
| Hill, AE | 1 |
| Dargatz, DA | 1 |
| Ladely, SR | 1 |
| Fedorka-Cray, PJ | 1 |
| Wardak, S | 1 |
| Szych, J | 1 |
| Duda, U | 1 |
| Feizabadi, MM | 1 |
| Dolatabadi, S | 1 |
| Zali, MR | 1 |
| Johnson, JY | 1 |
| McMullen, LM | 1 |
| Hasselback, P | 1 |
| Louie, M | 1 |
| Jhangri, G | 1 |
| Saunders, LD | 1 |
| Pasquali, F | 1 |
| Lucchi, A | 1 |
| Manfreda, G | 1 |
| Gallay, A | 1 |
| Bousquet, V | 1 |
| Siret, V | 1 |
| Prouzet-Mauléon, V | 1 |
| Valk, Hd | 1 |
| Vaillant, V | 1 |
| Simon, F | 1 |
| Le Strat, Y | 1 |
| Desenclos, JC | 1 |
| Reina, J | 2 |
| Ros, MJ | 1 |
| Fernandez-Baca, V | 1 |
| Beltinger, J | 1 |
| Simon, CH | 1 |
| Markusse, HM | 1 |
| Castiella, A | 1 |
| Yuste, R | 1 |
| Gonzalez, F | 1 |
| Martinez, S | 1 |
| Alzate, L | 1 |
| Arriola, JA | 1 |
| Arenas, JI | 1 |
| Elcuaz, R | 1 |
| Lluch-Perales, JF | 1 |
| Gómez, E | 1 |
| Suárez, J | 1 |
| Hernández, M | 1 |
| LaFarga, B | 1 |
| Hagensee, ME | 1 |
| Benyunes, M | 1 |
| Miller, JA | 1 |
| Spach, DH | 1 |
| Schwartz, D | 1 |
| Goossens, H | 1 |
| Levy, J | 1 |
| Butzler, JP | 1 |
| Goldhar, J | 1 |
| Peterson, MC | 1 |
| Farr, RW | 1 |
| Castiglia, M | 1 |
| Mirelis, B | 1 |
| Miro, E | 1 |
| Navarro, F | 1 |
| Ogalla, CA | 1 |
| Bonal, J | 1 |
| Prats, G | 1 |
| Kuschner, RA | 1 |
| Trofa, AF | 1 |
| Thomas, RJ | 1 |
| Hoge, CW | 1 |
| Pitarangsi, C | 2 |
| Amato, S | 1 |
| Olafson, RP | 1 |
| Echeverria, P | 3 |
| Sadoff, JC | 1 |
| Taylor, DN | 2 |
| Tee, W | 3 |
| Mijch, A | 2 |
| Wright, E | 1 |
| Yung, A | 1 |
| Murphy, GS | 2 |
| Jackson, LR | 1 |
| Arness, MK | 1 |
| LeBron, C | 1 |
| Slavin, MA | 1 |
| Jennens, I | 1 |
| Dryden, MS | 1 |
| Gabb, RJ | 1 |
| Wright, SK | 1 |
| Autenrieth, IB | 1 |
| Schuster, V | 1 |
| Ewald, J | 1 |
| Harmsen, D | 1 |
| Kreth, HW | 1 |
| Taylor, DE | 1 |
| Chau, AS | 1 |
| Williams, A | 1 |
| Atanassova, V | 1 |
| Ring, C | 1 |
| Besser, JM | 1 |
| Hedberg, CW | 1 |
| Leano, FT | 1 |
| Bender, JB | 1 |
| Wicklund, JH | 1 |
| Johnson, BP | 1 |
| Moore, KA | 1 |
| Osterholm, MT | 1 |
| Douchet, MP | 1 |
| Dugast, S | 1 |
| Zupan, M | 1 |
| Christmann, D | 1 |
| Binotto, E | 1 |
| McIver, CJ | 1 |
| Hawkins, GS | 1 |
| Collignon, PJ | 1 |
| Turnidge, JD | 1 |
| Zirnstein, G | 1 |
| Helsel, L | 1 |
| Li, Y | 1 |
| Swaminathan, B | 1 |
| Besser, J | 1 |
| Wilson, DL | 1 |
| Abner, SR | 1 |
| Newman, TC | 1 |
| Mansfield, LS | 1 |
| Linz, JE | 1 |
| Afset, JE | 1 |
| Maeland, JA | 1 |
| Gorman, C | 1 |
| Segreti, J | 2 |
| Gootz, TD | 1 |
| Goodman, LJ | 3 |
| Parkhurst, GW | 2 |
| Quinn, JP | 1 |
| Martin, BA | 1 |
| Trenholme, GM | 3 |
| Nelson, MR | 1 |
| Shanson, DC | 1 |
| Hawkins, DA | 1 |
| Gazzard, BG | 1 |
| Gracheva, NM | 1 |
| Partin, OS | 1 |
| Shcherbakov, IT | 1 |
| Ivanova, VI | 1 |
| Fokin, SN | 1 |
| Petruccelli, BP | 1 |
| Sanchez, JL | 1 |
| Walz, S | 1 |
| DeFraites, R | 1 |
| Gelnett, J | 1 |
| Haberberger, RL | 1 |
| Decker, CF | 1 |
| Martin, GJ | 1 |
| Barham, WB | 1 |
| Paparello, SF | 1 |
| Rao, RG | 1 |
| Adler-Mosca, H | 1 |
| Lüthy-Hottenstein, J | 1 |
| Martinetti Lucchini, G | 1 |
| Burnens, A | 1 |
| Altwegg, M | 1 |
| Labenz, J | 1 |
| Gyenes, E | 1 |
| Peitz, U | 1 |
| Börsch, G | 1 |
| Kaplan, RL | 2 |
| Hines, D | 1 |
| Petrak, R | 1 |
| Nelson, JA | 1 |
| Mayer, KW | 1 |
| Landau, W | 1 |
| Hamer, IE | 1 |
| Olczak, SA | 1 |
| Parkin, D | 1 |
| Forsmark, CE | 1 |
| Wilcox, CM | 1 |
| Cello, JP | 1 |
| Margaretten, W | 1 |
| Lee, B | 1 |
| Sachdeeva, M | 1 |
| Satow, J | 1 |
| Sande, MA | 1 |
| Petrak, RM | 1 |
| Fliegelman, RM | 1 |
| Taff, D | 1 |
| Walton, F | 1 |
| Penner, JL | 1 |
| Pichler, H | 1 |
| Diridl, G | 2 |
| Wolf, D | 2 |
| Stone, JW | 1 |
| Wise, R | 1 |
| Donovan, IA | 1 |
| Gearty, J | 1 |
| Pichler, HE | 1 |
| Stickler, K | 1 |
| Hirschl, AM | 1 |
| Stanek, G | 1 |
| Rotter, M | 1 |
| Hentschel, E | 1 |
| Schütze, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Double Blind, Placebo-Controlled Trial Assessing the Efficacy of Rifaximin in Preventing Campylobacteriosis in Subjects Challenged With Campylobacter Jejuni[NCT02280044] | Phase 2/Phase 3 | 30 participants (Actual) | Interventional | 2014-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"A clinical illness meeting at least one of the following patterns:~Moderate to severe diarrhea.~Fever (present on at least 2 occasions, at least 20 minutes apart) without diarrhea, plus an associated symptom (nausea, vomiting, abdominal cramps, tenesmus, or gross blood in ≥ 2 stools); with consideration of potential alternative diagnosis per clinical investigator based on illness time course and associated symptoms." (NCT02280044)
Timeframe: 120 hours after challenge
| Intervention | Participants (Count of Participants) |
|---|---|
| Rifaximin | 13 |
| Placebo | 11 |
Recovered C jejuni from fecal specimen on follow-up after an apparent cure (NCT02280044)
Timeframe: 84 Days
| Intervention | Participants (Count of Participants) |
|---|---|
| Rifaximin | 2 |
| Placebo | 3 |
4 reviews available for ciprofloxacin and Campylobacter Infection
| Article | Year |
|---|---|
Antimicrobial therapy of acute diarrhoea: a clinical review.
Topics: Acute Disease; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Campyloba | 2016 |
[Antibiotic resistance of bacteria Campylobacter sp].
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Ciprofloxacin; Drug Resista | 2010 |
Campylobacter fetus bacteremia in an immunocompromised patient: case report and review of the literature.
Topics: Adult; Bacteremia; Campylobacter fetus; Campylobacter Infections; Ciprofloxacin; Cytomegalovirus; Fe | 2004 |
Re-analysis of the risks attributed to ciprofloxacin-resistant Campylobacter jejuni infections.
Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Case-Control Studies; Ciprofl | 2007 |
7 trials available for ciprofloxacin and Campylobacter Infection
| Article | Year |
|---|---|
Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Campylobacter Infections; Campylobacter jejuni; Chemopre | 2018 |
Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Campylobacter; Campylobacter Infe | 1995 |
Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin.
Topics: Adult; Age Factors; Aged; Anti-Infective Agents; Campylobacter Infections; Ciprofloxacin; Community- | 1996 |
Treatment of traveler's diarrhea with ciprofloxacin and loperamide.
Topics: Campylobacter Infections; Ciprofloxacin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; D | 1992 |
Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults.
Topics: Adult; Bacterial Infections; Campylobacter fetus; Campylobacter Infections; Ciprofloxacin; Diarrhea; | 1990 |
Ciprofloxacin in the treatment of acute bacterial diarrhea: a double blind study.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Campylobacter fetus; Campylobacter Infections; Ci | 1986 |
Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Campylobacter fetus; Campylobacter Infections; | 1987 |
149 other studies available for ciprofloxacin and Campylobacter Infection
| Article | Year |
|---|---|
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapene | 2010 |
Campylobacter spp. prevalence and fluoroquinolone resistance in chicken layer farms.
Topics: Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; | 2022 |
Campylobacter jejuni and other emerging Campylobacteraceae in retail beef liver - an underestimated potential source?
Topics: Animals; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Campylobacteraceae; | 2022 |
Prevalence and antimicrobial resistance of Campylobacter and Salmonella in layer flocks in Honshu, Japan.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Campylobacter j | 2022 |
Isolation, identification and antibiotic resistance profile of thermophilic Campylobacter species from Bovine, Knives and personnel at Jimma Town Abattoir, Ethiopia.
Topics: Abattoirs; Agar; Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections | 2022 |
Distribution of Virulence Genes in
Topics: Agaricus; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; C | 2023 |
Antimicrobial resistance profiles of Campylobacter jejuni and Salmonella spp. isolated from enteritis patients in Japan.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter Infections; Campylo | 2023 |
SVR-flaA typing of erythromycin- and ciprofloxacin-resistant Campylobacter jejuni strains isolated from poultry slaughterhouses in southern Brazil.
Topics: Abattoirs; Animals; Anti-Bacterial Agents; Brazil; Campylobacter Infections; Campylobacter jejuni; C | 2023 |
Antimicrobial use and its association with the isolation of and antimicrobial resistance in Campylobacter spp. recovered from fecal samples from Canadian dairy herds: A cross-sectional study.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Canada; Cattle; Cattle Dise | 2023 |
Prevalence of ciprofloxacin resistance and associated genetic determinants differed among Campylobacter isolated from human and poultry meat sources in Pennsylvania.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Ciprofloxacin; Humans; Meat | 2023 |
Campylobacter jejuni and Campylobacter coli in human stool samples: antibiotic resistance profiles, putative virulence determinants and molecular characterization of the isolates.
Topics: Anti-Bacterial Agents; Campylobacter; Campylobacter coli; Campylobacter Infections; Campylobacter je | 2023 |
Antimicrobial Susceptibility of Campylobacter isolates in the Capital of North Macedonia.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter; | 2019 |
Molecular and phenotypical investigation of ciprofloxacin resistance among Campylobacter jejuni strains of human origin: high prevalence of resistance in Turkey.
Topics: Alleles; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Disk | 2020 |
(-)-α-Pinene reduces quorum sensing and Campylobacter jejuni colonization in broiler chickens.
Topics: Animals; Anti-Bacterial Agents; Bicyclic Monoterpenes; Campylobacter Infections; Campylobacter jejun | 2020 |
Prevalence and susceptibility to antibiotics from Campylobacter jejuni and Campylobacter coli isolated from chicken meat in southern Benin, West Africa.
Topics: Ampicillin Resistance; Animals; Benin; Campylobacter coli; Campylobacter Infections; Campylobacter j | 2020 |
Validation of the T86I mutation in the gyrA gene as a highly reliable real time PCR target to detect Fluoroquinolone-resistant Campylobacter jejuni.
Topics: Amino Acid Substitution; Campylobacter Infections; Campylobacter jejuni; Child; Ciprofloxacin; Diarr | 2020 |
Prevalence, molecular typing and antimicrobial susceptibility of Campylobacter spp. isolates in northern Spain.
Topics: Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; | 2021 |
Characterization of Campylobacter associated gastric enteritis among patients with Human Immunodeficiency Virus (HIV) in a hospital in Accra, Ghana.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Ciprofloxacin; Cr | 2020 |
Occurrence of Campylobacter spp. in Swedish calves, common sequence types and antibiotic resistance patterns.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Cattl | 2021 |
Prevalence and antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolated from children and environmental sources in urban and suburban areas.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Campylobacter coli; Campylobacter Infections; Campylob | 2017 |
Antibiotic susceptibility profiles among Campylobacter isolates obtained from international travelers between 2007 and 2014.
Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Campylobact | 2017 |
High Prevalence of Resistance to Fluoroquinolones and Tetracycline Campylobacter Spp. Isolated from Poultry in Poland.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Campylobacter coli; Campylobacter Infections; Ca | 2018 |
Clinical Pearls in Infectious Diseases 2017.
Topics: Administration, Intravaginal; Adult; Aged; Anti-Bacterial Agents; Body Piercing; Campylobacter Infec | 2017 |
Pericarditis caused by Campylobacter fetus subspecies fetus associated with ingestion of raw beef liver.
Topics: Animals; Anti-Bacterial Agents; Base Sequence; Campylobacter fetus; Campylobacter Infections; Cattle | 2017 |
Campylobacter jejuni vertebral osteomyelitis.
Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Humans; Male; | 2017 |
Genetic diversity and clonal characteristics of ciprofloxacin-resistant Campylobacter jejuni isolated from Chilean patients with gastroenteritis.
Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Chile; Ciprofloxacin; Drug Re | 2018 |
Campylobacter jejuni transcriptional and genetic adaptation during human infection.
Topics: Animals; Azithromycin; Bacterial Proteins; Campylobacter Infections; Campylobacter jejuni; Chickens; | 2018 |
Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli: comparison between Etest and a broth dilution method.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Ciproflox | 2018 |
Epidemiologic cutoff values to separate wild-type from non-wild-type Campylobacter fetus to ciprofloxacin.
Topics: Anti-Bacterial Agents; Campylobacter fetus; Campylobacter Infections; Ciprofloxacin; Fluoroquinolone | 2018 |
Topics: Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Biopsy, Needle; Campylobacter fetus; C | 2018 |
The Cipro conundrum: updated guidelines not completely translated to practice.
Topics: Anti-Infective Agents; Campylobacter Infections; Ciprofloxacin; Diarrhea; Drug Resistance, Microbial | 2018 |
Molecular epidemiology and antimicrobial resistance mechanisms of Campylobacter coli from diarrhoeal patients and broiler carcasses in Belgium.
Topics: Animals; Anti-Bacterial Agents; Belgium; Campylobacter coli; Campylobacter Infections; Chickens; Cip | 2019 |
Ciprofloxacin resistance among Campylobacter jejuni isolates obtained from shelter dogs in Texas.
Topics: Animals; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Cross-Sectional Studies; Dog | 2019 |
Antibiotic resistance of Campylobacter jejuni isolates recovered from humans with diarrhoea in Turkey.
Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Diarrhea; Disk | 2019 |
Long-term observation of antimicrobial susceptibility and molecular characterisation of Campylobacter jejuni isolated in a Japanese general hospital 2000-2017.
Topics: Bacterial Proteins; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; DNA Gyrase; Drug | 2019 |
Quinolone and Macrolide-Resistant
Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Child; Child, Preschool; Cipr | 2019 |
Biofilm formation, virulence and antimicrobial resistance of different Campylobacter jejuni isolates from a poultry slaughterhouse.
Topics: Abattoirs; Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; Biofilms; Campylobacter Infe | 2019 |
Topics: Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; | 2019 |
Characterization of clinical Campylobacter jejuni isolates with special emphasis on lipooligosaccharide locus class, putative virulence factors and host response.
Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Cell Line; Ciprofloxacin; Dox | 2013 |
Campylobacter coli outbreak in men who have sex with men, Quebec, Canada, 2010-2011.
Topics: Adult; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Ciprofloxacin; Coinfecti | 2013 |
[Incidence and susceptibility of Campylobacter jejuni in pediatric patients: involvement in bacteremia].
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Campylobacter Infections; Campylobacter jejuni; Child | 2013 |
[Accuracy of Etest method to study Campylobacter spp. susceptibility to erythromycin, ciprofloxacin and tetracycline].
Topics: Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Ciprofloxacin; Culture Media; Drug R | 2013 |
Epidemiological investigations on the possible risk of distribution of zoonotic bacteria through apparently healthy homing pigeons.
Topics: Adult; Animals; Anti-Bacterial Agents; Bird Diseases; Caco-2 Cells; Campylobacter Infections; Campyl | 2013 |
Burden of laboratory-confirmed Campylobacter infections in Guatemala 2008-2012: results from a facility-based surveillance system.
Topics: Adolescent; Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Campylobacter; Campylobacter I | 2014 |
Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli isolates obtained in Montreal, Quebec, Canada, from 2002 to 2013.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Ciproflox | 2014 |
Campylobacter jejuni bacteraemia in a patient presenting with gastroenteritis.
Topics: Administration, Intravenous; Adult; Bacteremia; Campylobacter Infections; Campylobacter jejuni; Cipr | 2014 |
[Resistance monitoring working group: resistance to erythromycin, ciprofloxacin, and tetracycline in human isolates of Campylobacter spp. in the Czech Republic tested by the EUCAST standard method].
Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Czech Republic | 2014 |
A single nucleotide change in mutY increases the emergence of antibiotic-resistant Campylobacter jejuni mutants.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Campylobacter Infections; Campylobacter jejuni; Catalytic | 2015 |
Long-Lasting Outbreak of Erythromycin- and Ciprofloxacin-Resistant Campylobacter jejuni Subspecies jejuni From 2003 to 2013 in Men Who Have Sex With Men, Quebec, Canada.
Topics: Adult; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Disease | 2015 |
Characterization of Antimicrobial Susceptibility and Its Association with Virulence Genes Related to Adherence, Invasion, and Cytotoxicity in Campylobacter jejuni and Campylobacter coli Isolates from Animals, Meat, and Humans.
Topics: Adhesins, Bacterial; Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; C | 2016 |
Fluoroquinolone and macrolide resistance in Campylobacter jejuni isolated from broiler slaughterhouses in southern Brazil.
Topics: Abattoirs; Animals; Anti-Bacterial Agents; Brazil; Campylobacter Infections; Campylobacter jejuni; C | 2016 |
High-Level Ciprofloxacin-Resistant Campylobacter jejuni Isolates Circulating in Humans and Animals in Incheon, Republic of Korea.
Topics: Animals; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Drug | 2016 |
Genetic diversity and antimicrobial resistance of Campylobacter and Salmonella strains isolated from decoys and raptors.
Topics: Animals; Animals, Wild; Anti-Infective Agents; Bird Diseases; Campylobacter; Campylobacter Infection | 2016 |
Methods to Study Antimicrobial Resistance in Campylobacter jejuni.
Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Culture Media; | 2017 |
Epidemiological relationships of Campylobacter jejuni strains isolated from humans and chickens in South Korea.
Topics: Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; Campylobacter Infections; Campylobacter | 2017 |
A survey of fluoroquinolone resistance in Escherichia coli and thermophilic Campylobacter spp. on poultry and pig farms in Great Britain.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Chickens; Ciprofloxacin; Dr | 2008 |
[Bacterial diarrheas and antibiotics: European recommendations].
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Campylobacter Infections; Campylobacter j | 2008 |
Severe diarrhoea caused by highly ciprofloxacin-susceptible Campylobacter isolates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Campylobacter coli; Campylobacter | 2009 |
Risk factors for ciprofloxacin-resistant Campylobacter infection in Wales.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Case-Contro | 2009 |
Antimicrobial resistance of Campylobacter species isolated from edible bivalve molluscs purchased from Bangkok markets, Thailand.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Ciprofloxacin; Drug Resista | 2009 |
Spondylodiscitis and an aortic aneurysm due to Campylobacter coli.
Topics: Aged; Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Bacteremia; Campylobacter coli; Campylobact | 2010 |
Antimicrobial resistance, virulence, and genotypic profile comparison of Campylobacter jejuni and Campylobacter coli isolated from humans and retail meats.
Topics: Animals; Animals, Domestic; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Cipr | 2010 |
Ciprofloxacin-resistant campylobacteriosis in the UK.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Ciprofloxacin; Drug Resista | 2010 |
Longitudinal on-farm study of the development of antimicrobial resistance in Campylobacter coli from pigs before and after danofloxacin and tylosin treatments.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter coli; Campylobacter Infections; Ciprofl | 2011 |
Lack of correlation between the 257C-to-T mutation in the gyrA gene and clinical severity of Campylobacter jejuni infection in a region of high incidence of ciprofloxacin resistance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Campylobacter Infections; Campylobacter jejuni; | 2011 |
Incidence and antimicrobial resistance profiling of Campylobacter in retail chicken livers and gizzards.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Chickens; Chloramphenicol; | 2012 |
Campylobacter jejuni cutaneous infection in a patient with graft versus host disease.
Topics: Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Erysipelas; Graft vs Host Disease; He | 2012 |
Campylobacter gastroenteritis associated with Sweet's syndrome.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Campylobacter Infections; Ciprofloxacin; Clob | 2012 |
Antimicrobial-resistant Campylobacter in the food chain in Mexico.
Topics: Abattoirs; Animals; Animals, Domestic; Anti-Bacterial Agents; Campylobacter; Campylobacter Infection | 2012 |
Campylobacter antimicrobial resistance in Peru: a ten-year observational study.
Topics: Anti-Bacterial Agents; Azithromycin; Campylobacter coli; Campylobacter Infections; Campylobacter jej | 2012 |
Campylobacter coli isolates from Finnish farrowing farms using aminopenicillins: high prevalence of bla(OXA-61) and β-lactamase production, but low MIC values.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactamases; Campylobacter coli; Campyl | 2012 |
Molecular epidemiology and public health relevance of Campylobacter isolated from dairy cattle and European starlings in Ohio, USA.
Topics: Animals; Campylobacter Infections; Campylobacter jejuni; Cattle; Ciprofloxacin; DNA, Bacterial; Drug | 2013 |
Absence of tetracycline resistance in Campylobacter coli isolates from Finnish finishing pigs treated with chlortetracycline.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Campylobacter coli; | 2013 |
Resistance to bile salts and sodium deoxycholate in macrolide- and fluoroquinolone-susceptible and resistant Campylobacter jejuni and Campylobacter coli strains.
Topics: Animals; Anti-Bacterial Agents; Bile Acids and Salts; Campylobacter coli; Campylobacter Infections; | 2013 |
Determination of antimicrobial sensitivities of Campylobacter jejuni isolated from commercial turkey farms in Germany.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Campylobacter Infections; Campylobacter jejuni; | 2012 |
gyrA polymorphism in Campylobacter jejuni: detection of gyrA mutations in 162 C. jejuni isolates by single-strand conformation polymorphism and DNA sequencing.
Topics: Anti-Infective Agents; Autoradiography; Campylobacter Infections; Campylobacter jejuni; Ciprofloxaci | 2002 |
Genetic basis of quinolone resistance and epidemiology of resistant and susceptible isolates of porcine Campylobacter coli strains.
Topics: Animals; Anti-Infective Agents; Campylobacter coli; Campylobacter Infections; Ciprofloxacin; DNA Gyr | 2002 |
Ciprofloxacin resistance in Campylobacter jejuni: case-case analysis as a tool for elucidating risks at home and abroad.
Topics: Adult; Campylobacter Infections; Campylobacter jejuni; Case-Control Studies; Chi-Square Distribution | 2002 |
In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump.
Topics: Animals; Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Chickens; Ciprofloxa | 2003 |
Ciprofloxacin-resistant Campylobacter.
Topics: Animals; Campylobacter; Campylobacter Infections; Chickens; Ciprofloxacin; Confounding Factors, Epid | 2003 |
Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland: association of ciprofloxacin resistance to travel destination.
Topics: Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Drug Resistanc | 2003 |
Antimicrobial resistance of Campylobacter jejuni subsp. jejuni strains isolated from humans in 1998 to 2001 in Montréal, Canada.
Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Drug Resistanc | 2003 |
Campylobacter jejuni isolated from poultry and humans in Styria, Austria: epidemiology and ciprofloxacin resistance.
Topics: Animals; Anti-Infective Agents; Austria; Bacterial Typing Techniques; Campylobacter Infections; Camp | 2003 |
Cluster of erythromycin- and ciprofloxacin-resistant Campylobacter jejuni subsp. jejuni from 1999 to 2001 in men who have sex with men, Québec, Canada.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; | 2003 |
Antibiotic resistance among Campylobacter jejuni/coli strains acquired in Sweden and abroad: a longitudinal study.
Topics: Anti-Bacterial Agents; Asia; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Cip | 2003 |
Antimicrobial susceptibility trends in Campylobacter jejuni and Campylobacter coli isolated from a rural Egyptian pediatric population with diarrhea.
Topics: Anti-Bacterial Agents; Azithromycin; Campylobacter coli; Campylobacter Infections; Campylobacter jej | 2003 |
Fluoroquinolone resistance trends and animal drug use: a retrospective analysis.
Topics: Animals; Anti-Infective Agents; Campylobacter; Campylobacter Infections; Chickens; Ciprofloxacin; Dr | 2004 |
Antimicrobial resistance among Campylobacter strains, United States, 1997-2001.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Chickens; Ciprofloxacin; Dr | 2004 |
Prolonged diarrhea due to ciprofloxacin-resistant campylobacter infection.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Campylobacter; Campylobacter Infections; Case-Contro | 2004 |
Prevalence and subtypes of ciprofloxacin-resistant Campylobacter spp. in commercial poultry flocks before, during, and after treatment with fluoroquinolones.
Topics: Animals; Anti-Bacterial Agents; Bacteriophage Typing; Campylobacter; Campylobacter Infections; Campy | 2005 |
Incidence and mechanism of ciprofloxacin resistance in Campylobacter spp. isolated from commercial poultry flocks in the United Kingdom before, during, and after fluoroquinolone treatment.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Chick | 2005 |
Ciprofloxacin resistance does not affect duration of domestically acquired campylobacteriosis.
Topics: Anti-Infective Agents; Campylobacter; Campylobacter Infections; Ciprofloxacin; Drug Resistance, Bact | 2005 |
Ciprofloxacin resistance among human Campylobacter isolates 1991-2004: an update.
Topics: Campylobacter; Campylobacter Infections; Ciprofloxacin; Drug Resistance, Bacterial; Feces; Humans; M | 2005 |
Effect of antibiotic sub inhibitory concentration on cytolethal distending toxin production by Campylobacter jejuni.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Toxins; Campylobacter Infections; Campyloba | 2005 |
Myocarditis in a patient with Campylobacter infection.
Topics: Adult; Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Chest Pain; Ciprofloxa | 2005 |
Relative contribution of target gene mutation and efflux to varying quinolone resistance in Irish Campylobacter isolates.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Biological Transport, | 2005 |
In vitro activities of 11 fluoroquinolones against 226 Campylobacter jejuni strains isolated from Finnish patients, with special reference to ciprofloxacin resistance.
Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Drug Resistanc | 2005 |
Campylobacter coli in swine production: antimicrobial resistance mechanisms and molecular epidemiology.
Topics: Abattoirs; Animals; Animals, Domestic; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infe | 2005 |
In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline- and ciprofloxacin-resistant Campylobacter clinical isolates.
Topics: Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Ciprofloxacin; Drug Resistance, Bact | 2006 |
Low-level fluoroquinolone resistance among Campylobacter jejuni isolates in Australia.
Topics: Australia; Campylobacter Infections; Campylobacter jejuni; Case-Control Studies; Ciprofloxacin; Drug | 2006 |
Phenotypic and genotypic anti-microbial resistance profiles of campylobacters from untreated feedlot cattle and their environment.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Cattle; Cattle Diseases; Ci | 2006 |
Dissemination of fluoroquinolone-resistant Campylobacter spp. within an integrated commercial poultry production system.
Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter coli; Campylobacter I | 2006 |
High level of ciprofloxacin resistance and its molecular background among Campylobacter jejuni strains isolated in the United Arab Emirates.
Topics: Anti-Infective Agents; Base Sequence; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; | 2006 |
Pattern of antibiotic susceptibility in Campylobacter jejuni isolates of human and poultry origin.
Topics: Animals; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Chickens; Ciprofloxa | 2007 |
Prevalence and antimicrobial resistance of Campylobacter in US dairy cattle.
Topics: Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; | 2007 |
[Antimicrobial susceptibilities of Campylobacter sp strains isolated from humans in 2005 to 2006 in Bielsko-Biala Region, Poland].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobac | 2007 |
Isolation and drug-resistant patterns of Campylobacter strains cultured from diarrheic children in Tehran.
Topics: Adolescent; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Child; Child, Presch | 2007 |
Risk factors for ciprofloxacin resistance in reported Campylobacter infections in southern Alberta.
Topics: Adult; Aged; Aged, 80 and over; Alberta; Anti-Bacterial Agents; Campylobacter; Campylobacter Infecti | 2008 |
Mutant prevention concentration of ciprofloxacin, enrofloxacin and nalidixic acid against Campylobacter jejuni.
Topics: Animals; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Drug | 2008 |
Risk factors for acquiring sporadic Campylobacter infection in France: results from a national case-control study.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Case-Contr | 2008 |
Resistance to erythromycin in fluoroquinolone-resistant Campylobacter jejuni strains isolated from human faeces.
Topics: Campylobacter Infections; Campylobacter jejuni; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Mul | 1995 |
[A case from practice (326). Dysentery (inflammatory diarrhea, cause Campylobacter jejuni].
Topics: Adult; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Dysentery; Female; Humans | 1995 |
Campylobacter jejuni arthritis in secondary amyloidosis.
Topics: Agammaglobulinemia; Aged; Amyloidosis; Arthritis, Infectious; Arthritis, Rheumatoid; Bacteremia; Cam | 1995 |
[Infection of ascitic fluid caused by Campylobacter jejuni in a patient with liver cirrhosis. A new case with an atypical presentation].
Topics: Ascitic Fluid; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Humans; Liver Cirrhosi | 1994 |
[Bacteremia caused by quinolone-resistant Campylobacter jejuni in a patient with HIV infection].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Bacteremia; Campylobacter Infec | 1994 |
Campylobacter jejuni bacteremia and Guillain-Barré syndrome in a patient with GVHD after allogeneic BMT.
Topics: Bacteremia; Bone Marrow Transplantation; Campylobacter Infections; Campylobacter jejuni; Ciprofloxac | 1994 |
Plasmid profiles and antimicrobial susceptibility of Campylobacter jejuni isolated from Israeli children with diarrhea.
Topics: Amoxicillin; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Child; Ciproflox | 1993 |
Prosthetic hip infection and bacteremia due to Campylobacter jejuni in a patient with AIDS.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Campylobacter Infections; Campylobacter jejuni; C | 1993 |
Increased resistance to quinolone in Catalonia, Spain.
Topics: Anti-Infective Agents; Campylobacter Infections; Ciprofloxacin; Drug Resistance, Microbial; Enteroba | 1993 |
Emergence of multidrug resistance in Campylobacter jejuni isolates from three patients infected with human immunodeficiency virus.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Campylob | 1995 |
Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Campylobacter; Campylobacter Infections; | 1996 |
Infection with ciprofloxacin-resistant Campylobacter jejuni in travellers returning from Asia.
Topics: Adult; Anti-Infective Agents; Asia; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; D | 1996 |
An unusual case of refractory Campylobacter jejuni infection in a patient with X-linked agammaglobulinemia: successful combined therapy with maternal plasma and ciprofloxacin.
Topics: Adoptive Transfer; Agammaglobulinemia; Anti-Infective Agents; Campylobacter Infections; Campylobacte | 1996 |
Cloning and nucleotide sequence of the gyrA gene from Campylobacter fetus subsp. fetus ATCC 27374 and characterization of ciprofloxacin-resistant laboratory and clinical isolates.
Topics: Amino Acid Sequence; Anti-Infective Agents; Base Sequence; Campylobacter fetus; Campylobacter Infect | 1997 |
First the chicken, then the egg; the heartburn came later.
Topics: Adult; Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Diagnos | 1997 |
Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review.
Topics: Adult; Aged; Bacteremia; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Drug Resista | 1998 |
[Campylobacter spp. in the surroundings of poultry meat production-- incidence and chinolone resistance].
Topics: Abattoirs; Animals; Anti-Infective Agents; Campylobacter; Campylobacter Infections; Campylobacter je | 1998 |
Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team.
Topics: Analysis of Variance; Animals; Anti-Infective Agents; Bacterial Typing Techniques; Campylobacter Inf | 1999 |
[Myopericarditis caused by Campylobacter jejuni].
Topics: Adult; Anti-Bacterial Agents; Aspirin; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin | 1999 |
Ciprofloxacin-resistant Campylobacter jejuni infections.
Topics: Adult; Animals; Anti-Infective Agents; Australia; Campylobacter Infections; Campylobacter jejuni; Ci | 2000 |
Antibiotic use in livestock.
Topics: Animal Husbandry; Animals; Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Ch | 2000 |
Characterization of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli by DNA sequence analysis and MAMA PCR.
Topics: Anti-Infective Agents; Base Sequence; Campylobacter coli; Campylobacter Infections; Ciprofloxacin; D | 2000 |
Identification of ciprofloxacin-resistant Campylobacter jejuni by use of a fluorogenic PCR assay.
Topics: Animals; Anti-Infective Agents; Base Sequence; Campylobacter Infections; Campylobacter jejuni; Cattl | 2000 |
FDA hastening withdrawal of fluoroquinolone approvals for poultry.
Topics: Animals; Anti-Infective Agents; Campylobacter; Campylobacter Infections; Chickens; Ciprofloxacin; Dr | 2000 |
[Erythromycin and ciprofloxacin resistant Campylobacter jejuni].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Ciprof | 2001 |
Staying healthy. Playing chicken with our antibiotics. Overtreatment is creating dangerously resistent germs.
Topics: Animals; Anthrax; Anti-Bacterial Agents; Campylobacter Infections; Ciprofloxacin; Drug Resistance, M | 2002 |
High-level quinolone resistance in clinical isolates of Campylobacter jejuni.
Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; Campylobacter Infections; Campylobacter je | 1992 |
Resistance to fluoroquinolones in Salmonella non-typhi and Campylobacter spp.
Topics: Campylobacter Infections; Ciprofloxacin; Drug Resistance, Microbial; Humans; Population Surveillance | 1992 |
Salmonella, Campylobacter and Shigella in HIV-seropositive patients.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Campylobacter Infections; CD4-Positive T-Lymphoc | 1992 |
[Chemotherapy of Campylobacter infections].
Topics: Adult; Age Factors; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Ciprofloxaci | 1992 |
Bacteremia due to Campylobacter cinaedi in a patient infected with the human immunodeficiency virus.
Topics: Adult; Bacteremia; Campylobacter Infections; Ciprofloxacin; HIV Infections; Humans; Male | 1992 |
Development of spontaneous resistance to ciprofloxacin in a strain of Campylobacter jejuni.
Topics: Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Drug Resistance, Microbial; Enteritis | 1991 |
Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin.
Topics: Adult; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; DNA, Bacte | 1991 |
[Ciprofloxacin-omeprazole combination therapy for eradication of Helicobacter pylori].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Campylobacter Infections; Ciprofloxacin; Drug | 1991 |
Mixed enteric infection.
Topics: Adult; Campylobacter Infections; Ciprofloxacin; Diarrhea; Dysentery, Bacillary; Egypt; Female; Human | 1990 |
Ciprofloxacin in the treatment of Helicobacter pylori in patients with gastritis and peptic ulcer.
Topics: Adult; Aged; Campylobacter Infections; Ciprofloxacin; Gastritis; Humans; Middle Aged; Peptic Ulcer | 1990 |
Effects of erythromycin and ciprofloxacin on chronic fecal excretion of Campylobacter species in marmosets.
Topics: Animals; Campylobacter; Campylobacter Infections; Ciprofloxacin; Erythromycin; Feces; Quinolines; Sa | 1986 |
Failure of ciprofloxacin to eradicate Campylobacter pylori from the stomach.
Topics: Campylobacter Infections; Ciprofloxacin; Gastritis; Humans; Microbial Sensitivity Tests; Stomach | 1988 |
[Duodenal ulcer and antibiotic therapy].
Topics: Campylobacter Infections; Ciprofloxacin; Drug Evaluation; Drug Therapy, Combination; Duodenal Ulcer; | 1987 |